Symposium 6: Precision Dosing in Psychiatry: TDM and PK/PD in the Psychiatric Patient Further Explained |
Tuesday September 15, 1200-1300 (UTC)
Sanne Kloosterboer, Erasmus MC, Netherlands
Birgit Koch, Erasmus MC, Netherlands
George Schoretsanitis, Zucker Hillside Hospital, USA
Learning Objectives: At the end of this session participants will be able to:
- Describe the current opinion of TDM of antipsychotics in general.
- Explain what is the PK of antipsychotics in children and when to do TDM in this population.
- Discuss what is the PK and the added value of TDM in pregnant patients with regard to antipsychotics and antidepressants.
Birgit Koch, Erasmus MC, Netherlands
George Schoretsanitis, Zucker Hillside Hospital, USA
Learning Objectives: At the end of this session participants will be able to:
- Describe the current opinion of TDM of antipsychotics in general.
- Explain what is the PK of antipsychotics in children and when to do TDM in this population.
- Discuss what is the PK and the added value of TDM in pregnant patients with regard to antipsychotics and antidepressants.